John Treanor

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects
    John Treanor
    Infectious Diseases Unit, University of Rochester School of Medicine, 601 Elmwood Avenue, Room 3 6308, Rochester, NY 14642 0001, USA
    Vaccine 24:254-62. 2006
  2. pmc B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant
    Jane Baer
    David H Smith Center for Vaccine Biology and Immunology, Aab Institute for Biomedical Sciences, Department of Microbiology and Immunology, Rochester, NY, USA
    Vaccine 28:907-15. 2010
  3. pmc Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines
    Michael E Pichichero
    University of Rochester, Rochester, NY, USA
    J Pediatr 155:495-9. 2009
  4. ncbi request reprint Psychosocial factors and the response to influenza vaccination in older adults
    Jan A Moynihan
    Department of Psychiatry, University of Rochester Medical Center, Box PSYCH, 300 Crittenden Blvd, Rochester, NY 14642, USA
    Psychosom Med 66:950-3. 2004
  5. pmc Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization
    Jessica L Halliley
    Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Vaccine 28:3582-7. 2010
  6. doi request reprint Recombinant proteins produced in insect cells
    John Treanor
    Infectious Diseases Division, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Curr Top Microbiol Immunol 333:211-25. 2009
  7. ncbi request reprint Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study
    Michael E Pichichero
    Department of Microbiology Immunology, University of Rochester, Rochester, New York, NY, USA
    Lancet 360:1737-41. 2002
  8. doi request reprint Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines
    Michael E Pichichero
    Department of Microbiology Immunology, Pediatrics, and Medicine, University of Rochester, Rochester, New York 14642, USA
    Pediatrics 121:e208-14. 2008
  9. pmc Simulation and prediction of the adaptive immune response to influenza A virus infection
    Ha Youn Lee
    Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York 14642, USA
    J Virol 83:7151-65. 2009
  10. ncbi request reprint Pandemic (avian) influenza
    Sumanth Rajagopal
    Department of Medicine, Infectious Diseases Division, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Semin Respir Crit Care Med 28:159-70. 2007

Collaborators

Detail Information

Publications28

  1. ncbi request reprint Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects
    John Treanor
    Infectious Diseases Unit, University of Rochester School of Medicine, 601 Elmwood Avenue, Room 3 6308, Rochester, NY 14642 0001, USA
    Vaccine 24:254-62. 2006
    ..Further evaluation of mucosal influenza immunization using the proteosome adjuvant/delivery system is clearly warranted...
  2. pmc B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant
    Jane Baer
    David H Smith Center for Vaccine Biology and Immunology, Aab Institute for Biomedical Sciences, Department of Microbiology and Immunology, Rochester, NY, USA
    Vaccine 28:907-15. 2010
    ..These observations suggest prior vaccination against H5 influenza HA induces cellular immune responses that cross-react among drifted variants, without precluding a response to new, or existing HA strains...
  3. pmc Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines
    Michael E Pichichero
    University of Rochester, Rochester, NY, USA
    J Pediatr 155:495-9. 2009
    ..We conducted a population-based pharmacokinetic study to assess blood levels and elimination of mercury after vaccination of premature infants born at > or =32 and <37 weeks of gestation and with birth weight > or =2000 but <3000 g...
  4. ncbi request reprint Psychosocial factors and the response to influenza vaccination in older adults
    Jan A Moynihan
    Department of Psychiatry, University of Rochester Medical Center, Box PSYCH, 300 Crittenden Blvd, Rochester, NY 14642, USA
    Psychosom Med 66:950-3. 2004
    ..We examined the influence of psychological state (depression, negative affect, perceived stress) and social support on pre- and post-vaccination response to influenza vaccine...
  5. pmc Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization
    Jessica L Halliley
    Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Vaccine 28:3582-7. 2010
    ..The kinetics of this response and the relationship of circulating ASCs to protective antibody titers have not been completely explored...
  6. doi request reprint Recombinant proteins produced in insect cells
    John Treanor
    Infectious Diseases Division, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Curr Top Microbiol Immunol 333:211-25. 2009
    ..Recombinant approaches may be extremely valuable in combating future pandemics and further studies of recombinant pandemic vaccines in humans are needed...
  7. ncbi request reprint Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study
    Michael E Pichichero
    Department of Microbiology Immunology, University of Rochester, Rochester, New York, NY, USA
    Lancet 360:1737-41. 2002
    ..We aimed to measure concentrations of mercury in blood, urine, and stools of infants who received such vaccines...
  8. doi request reprint Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines
    Michael E Pichichero
    Department of Microbiology Immunology, Pediatrics, and Medicine, University of Rochester, Rochester, New York 14642, USA
    Pediatrics 121:e208-14. 2008
    ..We conducted a pharmacokinetic study to assess blood levels and elimination of ethyl mercury after vaccination of infants with thimerosal-containing vaccines...
  9. pmc Simulation and prediction of the adaptive immune response to influenza A virus infection
    Ha Youn Lee
    Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York 14642, USA
    J Virol 83:7151-65. 2009
    ..We further compared alternative model structures, for example, B-cell activation directly by the virus versus that through professional antigen-presenting cells or dendritic cell licensing of CD8 T cells...
  10. ncbi request reprint Pandemic (avian) influenza
    Sumanth Rajagopal
    Department of Medicine, Infectious Diseases Division, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Semin Respir Crit Care Med 28:159-70. 2007
    ..g., adamantanes and neuraminidase inhibitors)...
  11. ncbi request reprint Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults
    John Treanor
    Department of Medicine, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, NY 14642, USA
    Vaccine 24:6913-23. 2006
    ..This suggests that local immune events in the tissue are distinct from the parameters measured in the peripheral blood...
  12. ncbi request reprint Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults
    John Treanor
    Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 20:1099-105. 2002
    ..These results suggest that when vaccine is in short supply, a strategy using a half dose in healthy adults could increase the number of people vaccinated with relatively little adverse impact on vaccine immunogenicity...
  13. ncbi request reprint Weathering the influenza vaccine crisis
    John Treanor
    Infectious Diseases Unit, University of Rochester Medical Center, Rochester, NY, USA
    N Engl J Med 351:2037-40. 2004
  14. ncbi request reprint Influenza vaccine--outmaneuvering antigenic shift and drift
    John Treanor
    Infectious Diseases Unit, University of Rochester Medical Center, Rochester, NY, USA
    N Engl J Med 350:218-20. 2004
  15. ncbi request reprint Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults
    Scott A Halperin
    Dalhousie University, Halifax, Nova Scotia, Canada
    Hum Vaccin 1:37-42. 2005
    ..We conclude that this trivalent, split virion, inactivated nasal influenza vaccine formulated with lipid/polysaccharide molecule carriers is well tolerated and modestly immunogenic in healthy adults...
  16. ncbi request reprint Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study
    Thuan Le
    UCLA Center for Vaccine Research, Research and Education Institute, Harbor UCLA Medical Center, UCLA School of Medicine, Torrance 90502, USA
    J Infect Dis 190:535-44. 2004
    ..These findings support the use of ACP booster immunizations for adolescents and adults, to provide sustained levels of antibody...
  17. ncbi request reprint Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children
    David I Bernstein
    Division of Infectious Diseases, Cincinnati Children s Hospital Medical Center, OH, USA
    Pediatr Infect Dis J 22:28-34. 2003
    ..The cold-adapted, trivalent influenza vaccine (CAIV-T) may become an option for annual vaccination. However, there is little information regarding the immune response to repeated immunization with CAIV-T...
  18. ncbi request reprint Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatrics 110:662-72. 2002
    ..To provide additional information on the safety of trivalent, cold-adapted influenza vaccine (CAIV-T) in children...
  19. ncbi request reprint Serum antibody responses after intradermal vaccination against influenza
    Robert B Belshe
    Department of Internal Medicine, Division of Infectious Diseases and Immunology, Saint Louis University, St Louis, MO 63110, USA
    N Engl J Med 351:2286-94. 2004
    ..If found to be safe and immunogenic, reduced doses of influenza vaccine given by the intradermal route could increase the number of available doses of vaccine...
  20. ncbi request reprint Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children
    Scott A Halperin
    Department of Pediatrics, Clinical Trials Research Center, Dalhousie University, IWK Health Centre, 5850 University Avenue, NS, B3J 3G9, Halifax, Canada
    Vaccine 20:1240-7. 2002
    ..We conclude that the cell culture-derived vaccine was safe and immunogenic in children, healthy adults and seniors...
  21. ncbi request reprint Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants
    H Fred Clark
    University of Pennsylvania School of Medicine, Philadelphia, and Merck and Co, Inc, West Point, Pennsylvania 19486, USA
    J Pediatr 144:184-90. 2004
    ..To investigate safety, efficacy, and immunogenicity of live quadrivalent rotavirus vaccine (QRV) containing human-bovine (WC3) reassortant rotavirus serotypes G1, G2, G3, and P1a...
  22. ncbi request reprint Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Rafael Harpaz
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, USA
    MMWR Recomm Rep 57:1-30; quiz CE2-4. 2008
    ..Before administration of zoster vaccine, patients do not need to be asked about their history of varicella (chickenpox) or to have serologic testing conducted to determine varicella immunity...
  23. pmc Cellular and humoral immunity following Snow Mountain virus challenge
    Lisa Lindesmith
    School of Public Health, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    J Virol 79:2900-9. 2005
    ..To our knowledge, this is the first report characterizing T-cell and cytokine responses following live norovirus challenge...
  24. ncbi request reprint Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)
    Joel I Ward
    University of California Los Angeles UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, David Geffen School of Medicine UCLA, Torrance, California 90502 2502, USA
    Clin Infect Dis 43:151-7. 2006
    ..Acellular pertussis (aP) booster immunizations have been recommended for adolescents and older persons to enhance long-term protection and to possibly reduce community transmission of infections...
  25. ncbi request reprint Recovery of drug-resistant influenza virus from immunocompromised patients: a case series
    Michael G Ison
    Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, 22908, USA
    J Infect Dis 193:760-4. 2006
    ..We describe a novel Asp198Asn NA mutation in an influenza B virus and its decreased susceptibility to both oseltamivir and zanamivir...
  26. ncbi request reprint Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment
    Luis Barroso
    Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA
    Antivir Ther 10:901-10. 2005
    ..Oseltamivir is the only oral neuraminidase inhibitor currently available; we determined the tolerability and antiviral efficacy of oral peramivir for treatment and prophylaxis of experimental human influenza A and B...
  27. ncbi request reprint Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults
    James D Cherry
    University of CaliforniaLos Angeles Center for Vaccine Research, Research and Education Institute, Harbor UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, USA
    Clin Infect Dis 39:1715-8. 2004
    ..There was minimal variation in antibody prevalence with respect to geographic area, age, sex, or race...
  28. ncbi request reprint Efficacy of an acellular pertussis vaccine among adolescents and adults
    Joel I Ward
    UCLA Center for Vaccine Research, Research and Education Institute, Harbor UCLA Medical Center, David Geffen School of Medicine, UCLA, Torrance, Calif 90502, USA
    N Engl J Med 353:1555-63. 2005
    ..This trial of an acellular pertussis vaccine among adolescents and adults evaluated the incidence of pertussis, vaccine safety, immunogenicity, and protective efficacy...